These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 37982646)

  • 1. A New Method for Constructing Macrophage-Associated Predictors of Treatment Efficacy Based on Single-Cell Sequencing Analysis.
    Lin J; Ran Y; Wu T; Wang Z; Zhao J; Tian Y
    J Immunother; 2024 Feb-Mar 01; 47(2):33-48. PubMed ID: 37982646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integration of single-cell and bulk RNA sequencing to establish a prognostic signature based on tumor-associated macrophages in colorectal cancer.
    Li H; Pan L; Guo J; Lao J; Wei M; Huang F
    BMC Gastroenterol; 2023 Nov; 23(1):385. PubMed ID: 37950156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer.
    Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X
    Front Immunol; 2022; 13():1056932. PubMed ID: 36479114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CAF signature predicts the prognosis of colorectal cancer patients: A retrospective study based on bulk RNA sequencing and single-cell RNA sequencing data.
    Liang C; Ji D; Qin F; Chen G
    Medicine (Baltimore); 2023 Mar; 102(10):e33149. PubMed ID: 36897717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CX3CR1 Acts as a Protective Biomarker in the Tumor Microenvironment of Colorectal Cancer.
    Yue Y; Zhang Q; Sun Z
    Front Immunol; 2021; 12():758040. PubMed ID: 35140706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and validation of TME-related signatures to predict prognosis and response to anti-tumor therapies in skin cutaneous melanoma.
    Lian W; Zheng X
    Funct Integr Genomics; 2023 May; 23(2):153. PubMed ID: 37160578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A mitophagy-related gene signature associated with prognosis and immune microenvironment in colorectal cancer.
    Zhang C; Zeng C; Xiong S; Zhao Z; Wu G
    Sci Rep; 2022 Nov; 12(1):18688. PubMed ID: 36333388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of prognostic biomarkers for cervical cancer based on programmed cell death-related genes and assessment of their immune profile and response to drug therapy.
    Feng S; Wang Z; Zhang H; Hou B; Xu Y; Hao S; Lu Y
    J Gene Med; 2024 Jan; 26(1):e3643. PubMed ID: 38044747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional enrichment analysis of LYSET and identification of related hub gene signatures as novel biomarkers to predict prognosis and immune infiltration status of clear cell renal cell carcinoma.
    Chen Y; He J; Jin T; Zhang Y; Ou Y
    J Cancer Res Clin Oncol; 2023 Dec; 149(18):16905-16929. PubMed ID: 37740762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Robust Hypoxia Risk Score Predicts the Clinical Outcomes and Tumor Microenvironment Immune Characters in Bladder Cancer.
    Liu Z; Tang Q; Qi T; Othmane B; Yang Z; Chen J; Hu J; Zu X
    Front Immunol; 2021; 12():725223. PubMed ID: 34484235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integration of single-cell RNA sequencing and bulk RNA transcriptome sequencing reveals a heterogeneous immune landscape and pivotal cell subpopulations associated with colorectal cancer prognosis.
    Zhang Q; Liu Y; Wang X; Zhang C; Hou M; Liu Y
    Front Immunol; 2023; 14():1184167. PubMed ID: 37675100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A senescence-based prognostic gene signature for colorectal cancer and identification of the role of SPP1-positive macrophages in tumor senescence.
    Yu S; Chen M; Xu L; Mao E; Sun S
    Front Immunol; 2023; 14():1175490. PubMed ID: 37090726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. M2 subtype tumor associated macrophages (M2-TAMs) infiltration predicts poor response rate of immune checkpoint inhibitors treatment for prostate cancer.
    JiaWei Z; ChunXia D; CunDong L; Yang L; JianKun Y; HaiFeng D; Cheng Y; ZhiPeng H; HongYi W; DeYing L; ZhiJian L; Xiao X; QiZhao Z; KangYi X; WenBing G; Ming X; JunHao Z; JiMing B; ShanChao Z; MingKun C
    Ann Med; 2021 Dec; 53(1):730-740. PubMed ID: 34032524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a hypoxia-related gene prognostic signature in colorectal cancer based on bulk and single-cell RNA-seq.
    Qiao Y; Jiang X; Li Y; Wang K; Chen R; Liu J; Du Y; Sun L; Li J
    Sci Rep; 2023 Feb; 13(1):2503. PubMed ID: 36781976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and Validation of a Prognostic Gene Signature Correlated With M2 Macrophage Infiltration in Esophageal Squamous Cell Carcinoma.
    Yao J; Duan L; Huang X; Liu J; Fan X; Xiao Z; Yan R; Liu H; An G; Hu B; Ge Y
    Front Oncol; 2021; 11():769727. PubMed ID: 34926275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrative transcriptional characterization of cell cycle checkpoint genes promotes clinical management and precision medicine in bladder carcinoma.
    Shi WW; Guan JZ; Long YP; Song Q; Xiong Q; Qin BY; Ma ZQ; Hu Y; Yang B
    Front Oncol; 2022; 12():915662. PubMed ID: 36033441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Robust Prognostic Signature of Tumor Microenvironment in Colorectal Cancer.
    Liu J; Yu F; Liu Z; Wang X; Li J
    Cancer Biother Radiopharm; 2022 Dec; 37(10):963-975. PubMed ID: 34551265
    [No Abstract]   [Full Text] [Related]  

  • 18. An immune-related gene prognostic index for predicting prognosis in patients with colorectal cancer.
    Li C; Wirth U; Schardey J; Ehrlich-Treuenstätt VV; Bazhin AV; Werner J; Kühn F
    Front Immunol; 2023; 14():1156488. PubMed ID: 37483596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of Exosome-Related Gene Risk Model to Evaluate the Tumor Immune Microenvironment and Predict Prognosis in Triple-Negative Breast Cancer.
    Qiu P; Guo Q; Yao Q; Chen J; Lin J
    Front Immunol; 2021; 12():736030. PubMed ID: 34659224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD4+ conventional T cells-related genes signature is a prognostic indicator for ovarian cancer.
    Hua T; Liu DX; Zhang XC; Li ST; Yan P; Zhao Q; Chen SB
    Front Immunol; 2023; 14():1151109. PubMed ID: 37063862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.